This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Omega Healthcare Investors (OHI) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Omega Healthcare Investors (OHI) closed at $35.02 in the latest trading session, marking a +1.42% move from the prior day.
Omega Healthcare to Buy MedEquities Realty in $600M Deal
by Zacks Equity Research
Omega Healthcare (OHI) will likely ride on growth curve, given its focus on accretive buyouts this year, after closing the sale of most of its assets and repositioning itself in 2018.
Company News For Jan 3, 2019
by Zacks Equity Research
Companies in the news are: GOOGL, TSLA, PRQR, OHI and MRT
5 High Yield Dividend Stocks That Gained More Than 30% in 2018
by Zacks Equity Research
These high dividend yield stocks have gained significantly this year and are likely to enhance portfolio returns.
Omega (OHI) in Focus: Stock Moves 5.5% Higher
by Zacks Equity Research
Omega (OHI) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.
Omega Healthcare Investors (OHI) Q3 FFO and Revenues Beat Estimates
by Zacks Equity Research
Omega Healthcare Investors (OHI) delivered FFO and revenue surprises of 1.32% and 0.49%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Host Hotels (HST) Beats on Q3 FFO & Revenues, Revises Outlook
by Zacks Equity Research
Host Hotels & Resorts' (HST) Q3 results reflect improvements in food and beverage sales, operations of Hyatt portfolio acquired and productivity gains, partly muted by impact of dispositions.
Omega Healthcare (OHI) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
Omega Healthcare (OHI) will likely experience higher rental income in third-quarter 2018. Also, we expect operator-transition efforts to support its performance.
Why Omega (OHI) Might Surprise This Earnings Season
by Zacks Equity Research
Omega (OHI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
What's in Store for W. P. Carey (WPC) This Earnings Season?
by Zacks Equity Research
W. P. Carey's (WPC) Q3 results likely to benefit from the company's high-quality portfolio and strategic investments.
Macerich (MAC) Q3 FFO Misses Estimates, Revenues Beat
by Zacks Equity Research
Macerich's (MAC) Q3 results highlight occupancy uptick, higher tenant sales, as well as improving same-center earnings.
Federal Realty (FRT) Q3 FFO & Revenues Top Estimates, View Up
by Zacks Equity Research
Federal Realty Investment Trust's (FRT) Q3 results highlight solid leasing activity and continued growth in property operating income.
Realty Income's (O) Q3 FFO & Revenues Surpass Estimates
by Zacks Equity Research
Realty Income's (O) Q3 results display year-over-year growth in revenues and high occupancy levels.
What's in the Cards for STORE Capital (STOR) in Q3 Earnings?
by Zacks Equity Research
STORE Capital's (STOR) Q3 result is likely to benefit from increase in property locations and customer base.
Will Elevated Supply Dampen Aimco's (AIV) Earnings in Q3?
by Zacks Equity Research
Aimco's (AIV) Q3 results are likely to reflect unfavorable impact of sluggish leasing activity and elevated supply in its markets.
Omega Healthcare Investors (OHI) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Omega Healthcare Investors (OHI) delivered earnings and revenue surprises of 1.33% and 1.46%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
REITs to Watch for Earnings on May 7: AIV, OHI, APLE & More
by Zacks Equity Research
While the Q1 earnings outlook for the finance sector remains encouraging, underlying asset categories and changing industry landscape are the key performance determinants for REITs.
Why Earnings Season Could Be Great for Omega Healthcare (OHI)
by Zacks Equity Research
Omega Healthcare (OHI) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
Omega Healthcare (OHI) Raises Dividend: Should You Buy?
by Zacks Equity Research
Omega Healthcare Investors (OHI) likely to draw investors' attention as the company's dividend yield surpasses the industry average of 4.1%.
Aging Americans to Aid Healthcare REITs: 3 Stocks to Buy Now
by Zacks Equity Research
Favorable demography amid the aging baby-boomer generation and greater longevity encourages healthcare REITs to tap opportunities and become resilient.
EPR Properties Declares Over 6% Dividend Hike: Time to Buy?
by Zacks Equity Research
EPR Properties (EPR) declared a 6.25% hike in its monthly dividend rate, delighting its shareholders. The company will now pay a dividend of 34 cents per share, up from 32 cents paid earlier.
Omega Healthcare (OHI) Hikes Dividend: Should You Buy?
by Zacks Equity Research
Omega Healthcare (OHI) stock is likely to draw investors' attention as the company's dividend yield surpasses the industry average of 4.39%.
4 REITs for Your Portfolio
by Jeremy Mullin
REITs offer income investors high dividends in a low rate environment.
Why Omega Healthcare Investors (OHI) is a Buy
by Jeremy Mullin
Growth & Income Stock Strategist, Todd Bunton, CFA, highlights Omega Healthcare Investors (OHI) on September 2, 2015.